Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-25-025179
Filing Date
2025-11-26
Accepted
2025-11-26 17:01:16
Documents
93
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A form10-ka.htm   iXBRL 10-K/A 2413108
2 EX-4.12 ex4-12.htm EX-4.12 110580
3 EX-19 ex19.htm EX-19 66587
4 EX-23.1 ex23-1.htm EX-23.1 3156
5 EX-31.1 ex31-1.htm EX-31.1 12577
6 EX-31.2 ex31-2.htm EX-31.2 12572
7 EX-32.1 ex32-1.htm EX-32.1 4531
8 EX-32.2 ex32-2.htm EX-32.2 4775
9 EX-97.1 ex97-1.htm EX-97.1 30891
  Complete submission text file 0001493152-25-025179.txt   10437901

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE bgms-20241231.xsd EX-101.SCH 71261
11 XBRL CALCULATION FILE bgms-20241231_cal.xml EX-101.CAL 71828
12 XBRL DEFINITION FILE bgms-20241231_def.xml EX-101.DEF 334944
13 XBRL LABEL FILE bgms-20241231_lab.xml EX-101.LAB 580951
14 XBRL PRESENTATION FILE bgms-20241231_pre.xml EX-101.PRE 453266
95 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 1606389
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Bio Green Med Solution, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-50626 | Film No.: 251531231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)